Some of the molecular alterations seen in SCLC include those in the pathways related to the oncogene MYC, the tumor suppressor genes RB1, TP53, and PTEN, NOTCH, and the chromatin regulator CREBBP41 [5]. This evidence concerns the gene RB1 and small cell lung carcinoma.